Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.

Gallot G, Vollant S, Saïagh S, Clémenceau B, Vivien R, Cerato E, Bignon JD, Ferrand C, Jaccard A, Vigouroux S, Choquet S, Dalle JH, Frachon I, Bruno B, Mothy M, Mechinaud F, Leblond V, Milpied N, Vié H.

J Immunother. 2014 Apr;37(3):170-9. doi: 10.1097/CJI.0000000000000031.

PMID:
24598452
2.

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15. Erratum in: Lancet Oncol. 2012 Apr;13(4):e134-5.

3.

HLA mismatches and hematopoietic cell transplantation: structural simulations assess the impact of changes in peptide binding specificity on transplant outcome.

Yanover C, Petersdorf EW, Malkki M, Gooley T, Spellman S, Velardi A, Bardy P, Madrigal A, Bignon JD, Bradley P.

Immunome Res. 2011;7(2):4.

4.

Granulocyte antibody screening: evaluation of a bead-based assay in comparison with classical methods.

Fromont P, Prié N, Simon P, Cesbron-Gautier A, Quelvennec E, Bignon JD, Muller JY, Audrain M.

Transfusion. 2010 Dec;50(12):2643-8. doi: 10.1111/j.1537-2995.2010.02762.x.

PMID:
20576014
5.

Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification.

Chainonthee W, Böttcher G, Gagne K, Füssel M, Bignon JD, Wassmuth R.

Tissue Antigens. 2010 Aug;76(2):135-43. doi: 10.1111/j.1399-0039.2010.01479.x. Epub 2010 Apr 8.

PMID:
20403144
6.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

7.

Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.

David G, Morvan M, Gagne K, Kerdudou N, Willem C, Devys A, Bonneville M, Folléa G, Bignon JD, Retière C.

Immunology. 2009 Oct;128(2):172-84. doi: 10.1111/j.1365-2567.2009.03085.x.

8.

Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.

Morvan M, Willem C, Gagne K, Kerdudou N, David G, Sébille V, Folléa G, Bignon JD, Retière C.

J Immunol. 2009 Jun 1;182(11):6727-35. doi: 10.4049/jimmunol.0900212.

9.

MICA compatibility and immunization in third kidney transplantations.

Gautier AC, Devys A, Cheneau ML, Simon PH, Martin C, Allard S, Hourmant M, Bignon JD.

Transplant Proc. 2009 Mar;41(2):663-5. doi: 10.1016/j.transproceed.2008.12.007.

PMID:
19328950
10.

Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.

Morvan M, David G, Sébille V, Perrin A, Gagne K, Willem C, Kerdudou N, Denis L, Clémenceau B, Folléa G, Bignon JD, Retière C.

Eur J Immunol. 2008 Dec;38(12):3474-86. doi: 10.1002/eji.200838407. Erratum in: Eur J Immunol. 2009 Jan;39(1):324.

11.

Anti-human leukocyte antigen antibodies after islet transplantation: what do they really mean?

Cantarovich D, Vistoli F, Bignon JD.

Transplantation. 2008 Jul 27;86(2):204-5. doi: 10.1097/TP.0b013e31817ba6e5. No abstract available.

PMID:
18645479
12.

The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.

Valentin N, Gagne K, Kerdudou N, Hallé L, Kaplan C, Killie MK, Skogen B, Muller JY, Bignon JD.

Transfusion. 2007 Dec;47(12):2322-9. Epub 2007 Aug 21.

PMID:
17714418
13.

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

Loiseau P, Busson M, Balere ML, Dormoy A, Bignon JD, Gagne K, Gebuhrer L, Dubois V, Jollet I, Bois M, Perrier P, Masson D, Moine A, Absi L, Reviron D, Lepage V, Tamouza R, Toubert A, Marry E, Chir Z, Jouet JP, Blaise D, Charron D, Raffoux C.

Biol Blood Marrow Transplant. 2007 Aug;13(8):965-74.

14.

Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.

Gagne K, Busson M, Balere-Appert ML, Absi L, Jollet I, Bignon JD, Bois M, Dormoy A, Dubois V, Gebuhrer L, Loiseau P, Masson D, Moine A, Perrier P, Reviron D, Charron D, Raffoux C; ARS 2000 FRM and FGM group.

Tissue Antigens. 2007 Apr;69 Suppl 1:118-22.

PMID:
17445183
15.

Preliminary analysis of a KIR haplotype estimation algorithm: a simulation study.

Gourraud PA, Gagne K, Bignon JD, Cambon-Thomsen A, Middleton D.

Tissue Antigens. 2007 Apr;69 Suppl 1:96-100.

PMID:
17445177
16.

[Post-transfusion acute lung injury (Trali) after plasma infusion in a patient having a constitutional thrombotic microangiopathy].

Betbèze V, Cottereau A, Bourreille G, Bignon JD, Masseau A, Muller JY, Hamidou M.

Rev Med Interne. 2007 Jul;28(7):498-500. Epub 2007 Mar 7. French.

PMID:
17397970
17.

Association of kidney transplant failure and antibodies against MICA.

Mizutani K, Terasaki P, Bignon JD, Hourmant M, Cesbron-Gautier A, Shih RN, Pei R, Lee J, Ozawa M.

Hum Immunol. 2006 Sep;67(9):683-91. Epub 2006 Jul 18.

PMID:
17002898
18.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.

19.

Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion.

Denis L, Sivula J, Gourraud PA, Kerdudou N, Chout R, Ricard C, Moisan JP, Gagne K, Partanen J, Bignon JD.

Tissue Antigens. 2005 Oct;66(4):267-76.

PMID:
16185321
20.

KIR matching in hematopoietic stem cell transplantation.

Bignon JD, Gagne K.

Curr Opin Immunol. 2005 Oct;17(5):553-9. Review.

PMID:
16085405

Supplemental Content

Loading ...
Support Center